Shop All Products
Free shipping on orders CA$150+
3rd-party lab tested — CoA on every batch
48hr dispatch · Discreet packaging
KLOW is the complete repair stack — four proven peptides in one vial. GHK-Cu (50mg) for gene-level tissue remodelling. BPC-157 (10mg) for angiogenesis and gut repair. TB-500 (10mg) for cell migration and systemic healing. KPV (10mg) for NF-κB-mediated inflammation control. Each peptide targets a different stage of the repair cascade. Together, they cover more ground than any single compound can. True North Peptides supplies KLOW at ≥99% purity per component in 80mg lyophilised vials. For research use only.
What Is KLOW?
KLOW is a precision-formulated 4-in-1 research blend built around the most complementary repair peptides in the catalogue. It's not a random stack — each component addresses a specific phase of the tissue repair and inflammation resolution cascade: GHK-Cu handles gene-level matrix remodelling, BPC-157 drives angiogenesis, TB-500 promotes cell migration and anti-inflammatory signalling, and KPV suppresses the NF-κB inflammatory cascade directly. Four different mechanisms, one vial.
GHK-Cu — 50mg (The Foundation)
The lead compound in the blend at 50mg. GHK-Cu modulates over 4,000 human genes including those governing collagen synthesis, DNA repair, and anti-ageing pathways. It provides the broad genetic foundation on which the other three peptides layer their specific repair mechanisms.
BPC-157 — 10mg (The Angiogenic Driver)
The most researched repair peptide in preclinical literature. BPC-157 promotes new blood vessel formation via VEGFR2 upregulation — bringing blood supply and nutrients to the repair site. It also protects gastrointestinal mucosal integrity and has studied effects on neurological signalling.
TB-500 — 10mg (The Cell Mobiliser)
The systemic cell migration specialist. TB-500 (Thymosin Beta-4 fragment) promotes endothelial cell and repair cell migration to injury sites via actin regulation, while modulating NF-κB to reduce the inflammatory cytokines that slow healing. Works synergistically with BPC-157's angiogenic activity.
KPV — 10mg (The Inflammation Controller)
The anti-inflammatory anchor. KPV directly inhibits NF-κB and reduces TNF-α, IL-1β, and IL-6 — the cytokines that, when left uncontrolled, turn acute tissue damage into chronic inflammation. Without inflammation control, the healing work done by the other three peptides is constantly being undermined.
Why a Blend vs Individual Peptides?
If you're running all four compounds anyway, KLOW simplifies preparation, guarantees consistent ratios across every research session, and provides a single quality reference covering all components. If you want to modify ratios or study individual peptides, True North Peptides stocks all four separately.
Product Specifications
Contents: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg | Total: 80mg | Purity: ≥99% per component | Storage: −20°C dry; 2–8°C post-reconstitution.
Store lyophilised product at -20°C or below. After reconstitution, store at 4°C and use within 30 days. Keep away from direct sunlight and moisture.
This product is intended for laboratory and research use only. Not for human or veterinary use. Must be handled by qualified researchers in an appropriate facility.
